Supplant is a biotechnology platform that makes sugar substitutes.
Supplant has raised $18.0M in total funding. The most recent round was Series A. The last funding was announced in October 2021.
Supplant's investors include Khosla Ventures, Coatue, Y Combinator, Felicis, EQT.
Supplant is headquartered in Cambridge, United Kingdom.
Supplant is a biotechnology platform that makes sugar substitutes.
Supplant is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Supplant — Funding & Investors." VCBacked, October 12, 2021, https://www.vcbacked.co/company/supplant-cambridge. Accessed July 25, 2026.
VCBacked. (2021). Supplant — Funding & Investors. Retrieved July 25, 2026, from https://www.vcbacked.co/company/supplant-cambridge
{{cite web |title=Supplant — Funding & Investors |url=https://www.vcbacked.co/company/supplant-cambridge |website=VCBacked |access-date=July 25, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated